Author:
Miyachi Hayato,Takemura Yuzuru,Kobayashi Hiroyuki,Ando Kiyoshi,Ando Yasuhiko
Reference17 articles.
1. The pharmacology and clinical use of methotrexate;Jolivet;N. Engl. J. Med.,1983
2. 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (TMQ), a potent non-classical folate antagonist inhibitor-I. Effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo;Bertino;Biochem. Phamacol.,1979
3. Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates;Fry;Cancer Res.,1988
4. Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5- methyl- 6-[(3,4,5-trimethoxyanilino)methyl]quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro;Kamen;Biochem. Pharmacol.,1984
5. Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance;Calvert;Eur. J. Cancer,1980
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献